Technologies such as gene, RNA, and cell therapies enable scientists to approach diseases in new ways. Great innovations in medicine such as Genome editing (also called gene editing) is a group of technologies that give scientists the ability to change an organism’s DNA. These technologies allow genetic material to be added, removed, or altered at specific locations in the genome. Several approaches to genome editing have been developed. Four Gene Editing Techniques: (1) Restriction Enzymes, (2) Zinc Finger Nucleases (ZFNs), (3) Transcription activator-like effector nucleases (TALENs) and (4) CRISPR-Cas9 gene editing revolutionized.
Scientists are developing gene therapies – treatments involving genome editing to prevent and treat diseases in humans. Genome editing tools have the potential to help treat diseases with a genomic basis, like cystic fibrosis and diabetes. There are two different categories of gene therapies: germline therapy and somatic therapy. Germline therapies change DNA in reproductive cells (like sperm and eggs). Changes to the DNA of reproductive cells are passed down from generation to generation. Somatic therapies, on the other hand, target non-reproductive cells, and changes made in these cells affect only the person who receives the gene therapy.
To read more about gene therapies and shared perspectives by various researchers and professors on the future of this technology go to the following links: